Series date: 
01/01/2023 - 7:00am to 12/31/2023 - 8:30am

TARGET AUDIENCE
This course is intended primarily for Nurses, Scientist Researchers, Allied Health Professionals, Students, and Clinical Research Coordinators; Lab Technicians; Other Research Staff.

LEARNING OBJECTIVES
Upon completion of this activity, participants should be able to:

  • Study staff will be able to develop an understanding about cancer and non-cancer diseases, treatment goals, staging (imaging, pathology), and current clinical trials by attending PI lead lecture.
  • Study staff will be able to demonstrate increased knowledge about diseases, treatment goals, and staging (imaging, pathology) by applying a new approach to their studies and patient care.

Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.



Credit Statement(s):
AMA

Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
ANCC
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 1.00 ANCC nursing contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
 
Disclosure Summary
As a provider accredited by Joint Accreditation for Interprofessional Continuing Education, Mayo Clinic College of Medicine and Science must ensure balance, independence, objectivity and scientific rigor in its educational activities.  All who are in a position to control the content are required to disclose all financial relationships with any ineligible company.   Faculty will also identify any off-label and/or investigational use of pharmaceuticals or instruments discussed in their content for FDA compliance.

 
Listed below are individuals with control of the content of this program who have disclosed...
 
Relevant financial relationship(s) with ineligible companies: 
Todd J. Schwedt - Consulting - Abbvie, Allergan, Axsome, Biodelivery Science, Biohaven, Click Therapeutics, Collegium, Eli Lilly, Ipsen, Linpharma, Lundbeck, Novartis, Satsuma, Tonix Pharma. Grant/Research - Amgen. Stock, Stock Options - Aural Analytics, Nocira
  

All relevant financial relationships have been mitigated.
 
No relevant financial relationship(s) with ineligible companies:
      Melissa Eden, Ph.D,; P.T, Marie (jay) Maningo-Salinas, Ph.D., Heidi Kogut, Janelle Yousef, Rebecca Bernard, RSS Coordinator, Carol LeDuc (added 7/6/23), and Kristin L. Black (added 8/31/23)
 
References to off-label usage(s) of pharmaceuticals or instruments in their presentation:
None
 
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s), please go here.
 
ATTENDANCE/CREDIT
Text the session code (provided only at the session) to 507-200-3010image within 48 hours of the live presentation to record attendance.  All learners are encouraged to text attendance regardless of credit needs.  This number is only used for receiving text messages related to tracking attendance.  Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows. 

COURSE DIRECTOR/S
Heidi Kogut
 
COORDINATOR/S
Carol LeDuc and Kristin Black
Support location: 
Arizona